Skip to main content
PMC home page
Heart logoLink to Heart
. 1996 Aug;76(2):101–102. doi: 10.1136/hrt.76.2.101

Homocysteine: the new player in the field of coronary risk.

G Montalescot
PMCID: PMC484451  PMID: 8795466

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alfthan G., Pekkanen J., Jauhiainen M., Pitkäniemi J., Karvonen M., Tuomilehto J., Salonen J. T., Ehnholm C. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis. 1994 Mar;106(1):9–19. doi: 10.1016/0021-9150(94)90078-7. [DOI] [PubMed] [Google Scholar]
  2. Arnesen E., Refsum H., Bønaa K. H., Ueland P. M., Førde O. H., Nordrehaug J. E. Serum total homocysteine and coronary heart disease. Int J Epidemiol. 1995 Aug;24(4):704–709. doi: 10.1093/ije/24.4.704. [DOI] [PubMed] [Google Scholar]
  3. Bienvenu T., Ankri A., Chadefaux B., Montalescot G., Kamoun P. Elevated total plasma homocysteine, a risk factor for thrombosis. Relation to coagulation and fibrinolytic parameters. Thromb Res. 1993 Apr 15;70(2):123–129. doi: 10.1016/0049-3848(93)90153-f. [DOI] [PubMed] [Google Scholar]
  4. Boushey C. J., Beresford S. A., Omenn G. S., Motulsky A. G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 1995 Oct 4;274(13):1049–1057. doi: 10.1001/jama.1995.03530130055028. [DOI] [PubMed] [Google Scholar]
  5. Ernst E., Resch K. L. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med. 1993 Jun 15;118(12):956–963. doi: 10.7326/0003-4819-118-12-199306150-00008. [DOI] [PubMed] [Google Scholar]
  6. Lolin Y. I., Sanderson J. E., Cheng S. K., Chan C. F., Pang C. P., Woo K. S., Masarei J. R. Hyperhomocysteinaemia and premature coronary artery disease in the Chinese. Heart. 1996 Aug;76(2):117–122. doi: 10.1136/hrt.76.2.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Montalescot G., Ankri A., Vicaut E., Drobinski G., Grosgogeat Y., Thomas D. Fibrinogen after coronary angioplasty as a risk factor for restenosis. Circulation. 1995 Jul 1;92(1):31–38. doi: 10.1161/01.cir.92.1.31. [DOI] [PubMed] [Google Scholar]
  8. Nygård O., Vollset S. E., Refsum H., Stensvold I., Tverdal A., Nordrehaug J. E., Ueland M., Kvåle G. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA. 1995 Nov 15;274(19):1526–1533. doi: 10.1001/jama.1995.03530190040032. [DOI] [PubMed] [Google Scholar]
  9. Perry I. J., Refsum H., Morris R. W., Ebrahim S. B., Ueland P. M., Shaper A. G. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet. 1995 Nov 25;346(8987):1395–1398. doi: 10.1016/s0140-6736(95)92407-8. [DOI] [PubMed] [Google Scholar]
  10. Renaud S., de Lorgeril M. The French paradox: dietary factors and cigarette smoking-related health risks. Ann N Y Acad Sci. 1993 May 28;686:299–309. doi: 10.1111/j.1749-6632.1993.tb39191.x. [DOI] [PubMed] [Google Scholar]
  11. Robinson K., Mayer E. L., Miller D. P., Green R., van Lente F., Gupta A., Kottke-Marchant K., Savon S. R., Selhub J., Nissen S. E. Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease. Circulation. 1995 Nov 15;92(10):2825–2830. doi: 10.1161/01.cir.92.10.2825. [DOI] [PubMed] [Google Scholar]
  12. Selhub J., Jacques P. F., Bostom A. G., D'Agostino R. B., Wilson P. W., Belanger A. J., O'Leary D. H., Wolf P. A., Schaefer E. J., Rosenberg I. H. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med. 1995 Feb 2;332(5):286–291. doi: 10.1056/NEJM199502023320502. [DOI] [PubMed] [Google Scholar]
  13. Shepherd J., Cobbe S. M., Ford I., Isles C. G., Lorimer A. R., MacFarlane P. W., McKillop J. H., Packard C. J. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995 Nov 16;333(20):1301–1307. doi: 10.1056/NEJM199511163332001. [DOI] [PubMed] [Google Scholar]
  14. Stampfer M. J., Malinow M. R., Willett W. C., Newcomer L. M., Upson B., Ullmann D., Tishler P. V., Hennekens C. H. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA. 1992 Aug 19;268(7):877–881. [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES